{"DataElement":{"publicId":"3532298","version":"1","preferredName":"Tumor Post Resection Pathologic Tumor Burden Value","preferredDefinition":"Numeric value of the sum of the maximum diameter of the new tumor as examined pathologically at the time of the surgical resection.","longName":"3532282v1.0:3162623v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3532282","version":"1","preferredName":"Tumor Post Resection Pathologic Tumor Burden","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Happening at a time subsequent to a reference time; later in time or order._The act of cutting out; the surgical removal of part or all of a structure or organ._A report that provides a description of the gross and microscopic examination of the specimen and is used to make a diagnosis and to determine treatment. It defines which structures and organs of the body are involved by the tumor, verifies the primary site of the cancer and describes the extent to which it has spread._Refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body. Also called tumor load.","longName":"2404687v1.0:3532280v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2404687","version":"1","preferredName":"Neoplasm","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0094ACAF-11BC-1BCA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-12","modifiedBy":"ONEDATA","dateModified":"2005-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3532280","version":"1","preferredName":"Post Excision Pathology Report Tumor Burden","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.:The act of cutting out; the surgical removal of part or all of a structure or organ. :The description of cells and tissues made by a pathologist based on microscopic evidence, and sometimes used to make a diagnosis of a disease.:Refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body. Also called tumor load.","longName":"C38008:C15232:C28277:C28384","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Excision","conceptCode":"C15232","definition":"The surgical removal of a lesion, often as part of a biopsy and with healthy margins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathology Report","conceptCode":"C28277","definition":"A report that provides a description of the gross and microscopic examination of the specimen and is used to make a diagnosis and to determine treatment. It defines which structures and organs of the body are involved by the tumor, verifies the primary site of the cancer and describes the extent to which it has spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Burden","conceptCode":"C28384","definition":"Refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C51CE6B9-E3A9-79E7-E040-BB89AD433104","latestVersionIndicator":"Yes","beginDate":"2012-07-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-18","modifiedBy":"ONEDATA","dateModified":"2012-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C51CE6B9-E3BA-79E7-E040-BB89AD433104","latestVersionIndicator":"Yes","beginDate":"2012-07-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by T.Lichtenberg. mc 7/24/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3162623","version":"1","preferredName":"Tumor Burden Value","preferredDefinition":"Refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body. Also called tumor load._A numerical quantity measured or assigned or computed.","longName":"3162623v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3162622","version":"1","preferredName":"Tumor Burden Value","preferredDefinition":"Refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body. Also called tumor load.:A numerical quantity measured or assigned or computed.","longName":"C28384:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Burden","conceptCode":"C28384","definition":"Refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95BAE1D8-FA76-9C93-E040-BB89AD4367EE","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"WHITES","dateCreated":"2010-11-23","modifiedBy":"ONEDATA","dateModified":"2010-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95BAE1D8-FA87-9C93-E040-BB89AD4367EE","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"WHITES","dateCreated":"2010-11-23","modifiedBy":"WHITES","dateModified":"2011-01-03","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 11/2010 sw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic Tumor Burden","type":"Preferred Question Text","description":"Pathologic Tumor Burden","url":null,"context":"NCIP"},{"name":"TCGA Form Instruction","type":"COMMENT","description":"This should include both well-differentiated and de-differentiated components.","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C51E4C58-F977-C540-E040-BB89AD437FF2","latestVersionIndicator":"Yes","beginDate":"2012-07-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-18","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Released per approval by T.Lichtenberg. mc 7/24/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}